|Videos|January 28, 2023

Glaucoma 360: Celebrate, educate and innovate

Author(s)David Hutton, Sheryl Stevenson

Glaucoma 360's co-founders and co-chairs Adrienne L. Graves, PhD, and Andrew G. Iwach, MD, speak with Ophthalmology Times® on what attendees can expect from the upcoming meeting, being held Feb. 2-4 in downtown San Francisco.

Listen as Glaucoma 360's co-founders and co-chairs, Adrienne L. Graves, PhD, and Andrew G. Iwach, MD, highlight the meeting, from the Annual Gala and the New Horizons Forum to the Glaucoma Symposia.

Glaucoma 360 will be held Feb. 2-4 at the Westin St. Francis San Francisco on Union Square in downtown San Francisco.

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Glaucoma 360: Celebrate, educate and innovate

Related Content

Frantz EyeCare LAL outcomes exceed national benchmarks in single-center cataract data

Emerging dry eye therapies and co-managing MGD: Ping Moore, OD

Why aren’t there enough ophthalmologists?

Personalizing dry eye treatment by addressing disease at its source

Root cause–based dry eye classification and the shift toward precision medicine

Latest CME

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

(COPE Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(CME Track) Reducing Treatment Burden in Retinal Disease Care With Extended-Duration Anti-VEGF Therapies

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

(COPE Track) Next-Generation Solutions for nAMD and DME: Bridging Evidence and Practice Gaps in Disease Management

(CME Track) Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension

(CME Track) Next-Generation Solutions for nAMD and DME: Bridging Evidence and Practice Gaps in Disease Management

Trending on Eye Care Network - Ophthalmology Times

EURETINA 2026: Retinal signs as diagnostic clues to systemic metabolic disease

MOGENRY earns Japan priority review for inherited retinal dystrophies

EURETINA 2026: Predicting geographic atrophy progression with DARC

Aldeyra to appeal FDA rejection of reproxalap as a treatment for dry eye disease

EURETINA 2026: OCT biomarkers that predict, preempt and pinpoint retinal disease